The uniform CE approval may give the impression that the European healthcare market is also uniformly regulated.
In fact, however, each country in Europe has its own reimbursement logic and decision-making structures.
Due to its size, the German market is particularly important. Experience from the German market is therefore often used as a reference for other countries, such as Switzerland, Austria, and Central and Eastern Europe.
Even outside Europe, Germany is regarded as a market-structuring reference point. In the German market, it becomes quickly apparent whether innovations are economically viable in everyday healthcare. This is because the German market does not follow free market rules. It is strictly regulated with a clearly defined system and reimbursement pathways and healthcare settings.
A reimbursement analysis can serve as an initial assessment for your technology by showing whether, where, and under what conditions the technology can be reimbursed. This is particularly important because the self-pay market plays only a minor role in Germany. Technologies are generally only successful if they are reimbursed by health insurance companies.
Reimbursement analyses are generally the first step toward a successful and sustainable market access strategy. Understanding the complex German reimbursement system is key to laying the foundation for a robust and successful market access strategy.
At Healthcare Heads, we are experts in reimbursement and market access in the German healthcare market.
Get in touch now for a complimentary initial consultation.
Author: Healthcare Heads GmbH
Phone: +49 431 800 1470
E-Mail: info@healthcareheads.com